Depomed to Report Fourth Quarter Fiscal Year 2016 Financial Results on Tuesday, February 21, 2017
February 17 2017 - 8:00AM
Depomed, Inc. (NASDAQ:DEPO) today announced that it will release
fourth quarter fiscal year 2016 financial results after the close
of market, Tuesday, February 21, 2017. The Company will host a
conference call beginning at 4:30 p.m. EST (1:30 p.m. PST) to
discuss its results.
Participants can access the call by dialing (866) 643-3010
(United States) or (857) 270-6032 (International) referencing
Conference ID 71033060. The conference call will also be available
via a live webcast on the Investor Relations section of Depomed's
website at http://www.depomed.com. Please access the website 15
minutes prior to the start of the call to download and install any
necessary audio software. An archived webcast replay will be
available on the Company's website for three months.
About Depomed
Depomed is a leading specialty pharmaceutical company focused on
enhancing the lives of the patients, families, physicians,
providers and payors we serve through commercializing innovative
products for pain and neurology related disorders. Depomed markets
six medicines with areas of focus that include mild to severe acute
pain, moderate to severe chronic pain, neuropathic pain, migraine
and breakthrough cancer pain. Depomed is headquartered in Newark,
California. To learn more about Depomed, visit www.depomed.com.
INVESTOR AND MEDIA CONTACT:
Christopher Keenan
VP, Investor Relations and Corporate Communications
510-744-8000
ckeenan@depomed.com
Depomed, Inc. (delisted) (NASDAQ:DEPO)
Historical Stock Chart
From Mar 2024 to Apr 2024
Depomed, Inc. (delisted) (NASDAQ:DEPO)
Historical Stock Chart
From Apr 2023 to Apr 2024